热门资讯> 正文

Adial Pharmaceuticals申请为股东出售237万股普通股

2024-04-13 04:35

Adial Pharmaceuticals (NASDAQ:ADIL) on Friday filed a prospectus related to the proposed resale of 2.37M common shares by the selling stockholders.
This prospectus is not an offer to sell these securities.
SEC Filing

More on Adial Pharmaceuticals

Adial stock rallies 81% on data for alcohol abuse drug
Seeking Alpha’s Quant Rating on Adial Pharmaceuticals

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。